Labinovation Technologies Inc-Shanghai Dongsin

Labnovation Technologies, Inc. is a China-based in-vitro diagnostics and clinical laboratory technology company specializing in the research, development, manufacturing, and marketing of diagnostic instruments and reagents. Established in 1997 and headquartered in Shenzhen, Guangdong, Labnovation has developed a growing international presence, supplying clinical laboratories and healthcare institutions across more than 90 countries. The company’s portfolio encompasses HbA1c analyzers and reagents, hematology reagents, clinical chemistry reagents, urine analysis reagents, ISE reagents, rapid diagnostic products, and related laboratory solutions. Labnovation is particularly recognized for its HbA1c and hematology solutions, including automated and point-of-care diagnostic platforms designed to support efficient, accurate, and cost-effective laboratory testing. Labnovation emphasizes international quality standards across its research, manufacturing, and quality-control processes. The company holds ISO 13485:2016 and ISO 9001:2015 certifications, while its products include CE-marked and FDA-registered offerings. It also maintains a dedicated R&D focus, investing a significant portion of annual sales into product development and innovation. Through its combination of diagnostic technology, manufacturing capabilities, international partnerships, and technical support, Labnovation aims to provide reliable and accessible IVD solutions to clinical laboratories worldwide.